Navigation Links
MHA Announces Gloria Barr, Esq. as Vice President & General Counsel
Date:8/17/2009

FLORHAM PARK, N.J., Aug. 17 /PRNewswire/ -- Managed Health Care Associates, Inc. (MHA) is pleased to announce that Gloria Barr, Esq., has joined MHA as Vice President & General Counsel. In this newly created role, Gloria will have overall responsibility for all legal matters for the company, including healthcare compliance, contract review and all corporate matters. Stephen J. Andrew, COO and CFO of MHA commented "The establishment of this important role in our Company represents yet another step in the continued growth of MHA."

Prior to joining MHA Gloria spent 8 years with Cardinal Health where she provided counsel to the Pharmaceutical Technologies and Services segment, a leading provider of contract manufacturing, packaging and development services to the pharmaceutical and biotechnology industries. Gloria's role as member of the management team included negotiating commercial agreements, licensing arrangements and strategic alliances as well as providing support and training to the company's global sales organization. When the segment was sold and renamed Catalent Pharma Solutions, Gloria served as VP, Deputy General Counsel and served on the executive team that managed the transition and separation from Cardinal Health. In this capacity she built and led a full service legal department and initiated the establishment of corporate governance and compliance policies for the newly independent company. Earlier in her career, Gloria was Assistant General Counsel at Warner Lambert Company and before that an associate at the law firm of Davis Polk & Wardwell. Gloria brings to MHA both knowledge of the pharmaceutical healthcare industry and experience as a business partner to her in-house clients.

About MHA

Managed Health Care Associates, Inc. (MHA) is the largest Alternate Site GPO in the country servicing the Long Term Care, Home Infusion, Combo Pharmacy and Specialty Pharmacy industries. MHA continues to lead the way in defining what an Alternate Site GPO can do for its members with a highly diversified healthcare services portfolio that also includes the leading Long Term Care Pharmacy Network; RxPertise, the leading clinical consultant pharmacy software servicing the long-term care industry; and Pharmaceutical Data Services. MHA's success is driven by unparalleled member support, competitive contracts, and the ability to create sophisticated, customized, web tools and reports, designed to increase savings and promote profitability. Members utilize MHA services to assist in the purchasing of a complete line of pharmaceuticals, medical supplies, capital equipment, and nutritional food, as well as network access to the majority of the largest national and regional prescription drug plans managing the Medicare Part D drug benefit. MHA also offers a variety of other services including contract administration, marketing, and continuing education. For more information, visit www.mhainc.com.

    For More Information Contact: Angela Elsier
    Director of Marketing
    Managed Health Care Associates, Inc.
    800-642-3020 X 2870
    aelsier@mhainc.com


'/>"/>
SOURCE Managed Health Care Associates, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LifeCare Holdings, Inc. Announces Second Quarter Results
2. Secretary Shinseki Announces Expansion of Counseling for Combat Veterans
3. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter Fiscal 2010 Financial Results
4. Purple Communications(TM) Announces Second Quarter 2009 Results
5. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
6. Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion
7. TrinityCare Senior Living, Inc. Announces Second Quarter Operating Results
8. Pregis Announces Second Quarter 2009 Financial Results
9. InfoLogix Announces Second Quarter Financial Results
10. Select Medical Corporation Announces Results for Second Quarter Ended June 30, 2009
11. Cardica Announces Fiscal 2009 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership ... affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over the ...
(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with ... participating in a research study that focuses on family interactions when dealing with dietary ... aspects of adults who have gluten sensitivities who cohabitate with other adults who may ...
(Date:8/19/2017)... , ... August 19, 2017 , ... ... that it is the first organization with pending recognition status from the Centers ... Program (“DPP”) via group telehealth classes and live video conferencing. , The ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... joined its Orlando location as an interventional pain management physician. He brings a ... the treatment of migraine headaches, and significant experience in spinal cord stimulation for ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport ... a definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology: